Company news

Dr. Yiwei Shu, Chairman of Shenzhen Biorocks Biotechnology Co., Ltd. and a PhD graduate of the Hong Kong University of Science and Technology, was invited to Invest Hong Kong's 25th anniversary celebration as a representative of an innovation company supported by Hong Kong. He joined Hong Kong Chief Executive John Lee and guests from across the community at the event.

Expand North Star 2024, a global event for startups and investors, was held in Dubai from October 13 to 16. Biorocks was the only company selected from the Guangdong-Hong Kong-Macao Greater Bay Area, ranked first, and received the organizers' sole fully sponsored exhibition place.

In March 2023, the China Association for Science and Technology announced the 2022 Innovation China Youth Entrepreneurship List. Biorocks Co-Founder Dr. Honam Chan was selected for its Shenzhen U30 list following a multi-stage evaluation process.

The Shenzhen SME Service Bureau recently announced its 2023 list of Specialized, Sophisticated, Distinctive and Innovative SMEs. Shenzhen Biorocks Biotechnology Co., Ltd. was included on the list, confirming that it met the city's recognition criteria.

From September 14 to 19, 2026, the 19th National Conference on Laboratory Animal Science and Technology was held in Shenyang, Liaoning. Horizon Biochip Limited, together with its parent company Shenzhen Biorocks Biotechnology Co., Ltd., started from a single mouse embryo and joined industry partners to discuss **standardization, reproducibility, and automation** in laboratory animal resource preservation.